Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil ; volume:17 ; number:1 ; day:17 ; month:7 ; year:2019 ; pages:1-6 ; date:12.2019
World journal of surgical oncology ; 17, Heft 1 (17.7.2019), 1-6, 12.2019
- Urheber
-
Ohkura, Yu
Ueno, Masaki
Udagawa, Harushi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-019-1665-x
- URN
-
urn:nbn:de:101:1-2019120912525841721745
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ohkura, Yu
- Ueno, Masaki
- Udagawa, Harushi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Febrile neutropenia : with 32 tables
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Febrile neutropenia : with 32 tables
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
Chemotherapy and febrile neutropenia - diagnostic and therapeutic management
Febrile neutropenia : with 32 tables
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy
Diagnostics and therapy of paediatric patients with febrile neutropenia
Bacterial infection profiles in lung cancer patients with febrile neutropenia
Time to antibiotics and outcomes in cancer patients with febrile neutropenia
Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia
Risk stratification for febrile neutropenia in patients with testicular germ cell tumors
Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia